BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3512226)

  • 1. [Continuing anti-anginal effectiveness during chronic nitrate therapy in spite of the cessation of hemodynamic partial effects].
    Kaltenbach M; Schneider W
    Dtsch Med Wochenschr; 1986 Mar; 111(10):383-6. PubMed ID: 3512226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
    Aronow S
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term effect of organic nitrates in angina pectoris: dependence on the form of administration and mode of stress].
    Schneider W; Bussmann WD; Kober G; Kaltenbach M
    Z Kardiol; 1989; 78 Suppl 2():83-7; discussion 115-7. PubMed ID: 2531510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamic and anti-angina effects of transdermal nitroglycerin after acute and chronic administration. Additive effect of sublingual isosorbide dinitrate].
    Scardi S; Pandullo C; Pivotti F; Ceschia G; Pollavini G
    G Ital Cardiol; 1986 Nov; 16(11):895-903. PubMed ID: 3104123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equal anti-ischemic properties of isosorbide dinitrate plus verapamil and isosorbide dinitrate plus propranolol. A randomized, double-blind and crossover study.
    Silber S; Vogler A; Theisen K
    Z Kardiol; 1986; 75 Suppl 3():100-5. PubMed ID: 3541414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease.
    Uberbacher HJ; Steinorth G; Glocke M; Abshagen U
    Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
    Kośmicki M; Sadowski Z; Szwed H; Kowalik I
    Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dose-response behavior and long-term effect of organic nitrates. Experimental and clinical studies].
    Schneider W
    Fortschr Med; 1989 Jun; 107(19):34, 37-8. PubMed ID: 2503432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
    Reiniger G; Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Avoidance of tolerance development to long term therapy with nitrates through correct dosage].
    Blasini R; Reiniger G; Rudolph W
    Z Kardiol; 1986; 75 Suppl 3():42-9. PubMed ID: 3541418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrate tolerance: the lack of effect of N-acetylcysteine.
    Parker JO; Farrell B; Lahey KA; Rose BF
    Circulation; 1987 Sep; 76(3):572-6. PubMed ID: 3304705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance development during isosorbide dinitrate treatment: can it be circumvented?
    Rudolph W; Blasini R; Reiniger G; Brügmann U
    Z Kardiol; 1983; 72 Suppl 3():195-8. PubMed ID: 6421009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dose-response relationship of nitrate therapy of angina pectoris].
    Schneider W; Kaltenbach M
    Z Kardiol; 1986; 75 Suppl 3():61-7. PubMed ID: 3099486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of eccentric dosing with sustained-release isosorbide dinitrate in patients with angina pectoris.
    Parker JO; Baird MG
    Can J Cardiol; 1994 Nov; 10(9):909-12. PubMed ID: 7954026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
    Brügmann U; Blasini R; Rudolph W
    Herz; 1984 Aug; 9(4):244-52. PubMed ID: 6434387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of antianginal efficacy of long-acting sustained release isosorbide dinitrate in comparison with short-acting isosorbide dinitrate.
    Rao YV; Reddy KS; Wasir HS
    Indian Heart J; 1991; 43(2):97-100. PubMed ID: 1752623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of various combination therapies in patients with coronary heart disease].
    Lehmann G; Reiniger G; Wolf H; Beyerle A; Rudolph W
    Herz; 1990 Dec; 15(6):399-409. PubMed ID: 1980660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.